USANA Health Sciences (NYSE:USNA) Stock Price Passes Above 200 Day Moving Average - Should You Sell?

Key Points

• USANA Health Sciences shares have surpassed their 200-day moving average of $29.54, trading at $30.57 after reaching a high of $30.62.
• Wall Street analysts have upgraded USANA Health Sciences' rating from "hold" to "buy," with a current average price target of $36.00.
• The company reported a net margin of 3.79% for the last quarter, exceeding revenue expectations at $235.85 million, which was above the $225.20 million estimate.

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $29.54 and traded as high as $30.62. USANA Health Sciences shares last traded at $30.57, with a volume of 109,330 shares.

USANA Health Sciences Price Performance

The stock has a market capitalization of $541.89 million, a price-to-earnings ratio of 16.48, a PEG ratio of 0.98 and a beta of 0.64. The business's 50-day simple moving average is $30.83 and its two-hundred day simple moving average is $29.55.

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The company reported $0.74 EPS for the quarter, topping analysts' consensus estimates of $0.54 by $0.20. The business had revenue of $235.85 million for the quarter, compared to analysts' expectations of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. USANA Health Sciences has set its FY 2025 guidance at 2.350-3.000 EPS. As a group, sell-side analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insiders Place Their Bets

In related news, Director Gilbert A. Fuller sold 1,058 shares of USANA Health Sciences stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $29.10, for a total value of $30,787.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider David Mulham Mulham sold 3,515 shares of USANA Health Sciences stock in a transaction on Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total transaction of $106,363.90. Following the completion of the sale, the insider owned 9,260 shares of the company's stock, valued at approximately $280,207.60. This trade represents a 27.51% decrease in their position. The disclosure for this sale can be found here. 0.63% of the stock is currently owned by insiders.

Institutional Investors Weigh In On USANA Health Sciences

Several institutional investors have recently bought and sold shares of the stock. PNC Financial Services Group Inc. lifted its holdings in USANA Health Sciences by 339.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock valued at $27,000 after acquiring an additional 771 shares during the last quarter. Versant Capital Management Inc boosted its position in USANA Health Sciences by 542.5% during the first quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $31,000 after purchasing an additional 971 shares during the period. Parallel Advisors LLC grew its holdings in USANA Health Sciences by 8,141.2% during the first quarter. Parallel Advisors LLC now owns 1,401 shares of the company's stock valued at $38,000 after purchasing an additional 1,384 shares during the last quarter. Tower Research Capital LLC TRC grew its holdings in USANA Health Sciences by 382.5% during the second quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company's stock valued at $73,000 after purchasing an additional 1,901 shares during the last quarter. Finally, CWM LLC grew its holdings in USANA Health Sciences by 109.7% during the second quarter. CWM LLC now owns 2,762 shares of the company's stock valued at $84,000 after purchasing an additional 1,445 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.